Table 2.
Characteristic | MDRD | CKD-EPI | Cockroft-Gault | |
---|---|---|---|---|
All patients | ||||
n | 13 396 | 13 396 | 11 868 | |
eGFR (mL/min) (median, IQR) | 98.6 (84.4–115.6) | 110.4 (96.9–119.6) | 110.7 (91.4–133.7) | |
Baseline eGFR category (n, %) | >90 | 8 769 (66) | 11 138 (83) | 9 105 (77) |
60–89 | 4 221 (32) | 2 065 (15) | 2 527 (21) | |
30–59 | 383 (3) | 177 (1) | 225 (2) | |
15–29 | 18 (0.1) | 12 (0.1) | 9 (0.1) | |
<15 | 5 (0.04) | 4 (0.03) | 2 (0.02) | |
Baseline and subsequent eGFR | ||||
n | 11 112 | 11 112 | 9 283 | |
eGFR (mL/min) (median, IQR) | 98.5 (84.5–115.1) | 110.4 (97.1–119.6) | 111.9 (92.8–134.9) | |
Baseline eGFR category (n, %) | >90 | 7 273 (66) | 9 283 (84) | 7 267 (78) |
60–89 | 3 541 (32) | 1 701 (15) | 1 865 (20) | |
30–59 | 286 (3) | 120 (1) | 146 (2) | |
15–29 | 12 (0.1) | 8 (0.1) | 5 (0.1) | |
<15 | 0 | 0 | 0 |
CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; MDRD: Modification of Diet in Renal Disease.